What is NDC 51662-1638?

51662-1638 is the product NDC for BUPIVACAINE HYDROCHLORIDE injection, solution, Bupivacaine hydrochloride 5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

BUPIVACAINE HYDROCHLORIDE injection, solution.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for BUPIVACAINE HYDROCHLORIDE injection, solution?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 51662-1638

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1638Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1638Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1638-3	5166216380351662163803	25 POUCH in 1 CASE (51662-1638-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1638-2) / 50 mL in 1 VIAL, MULTI-DOSEMarketed from Oct 2, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): BUPIVACAINE HYDROCHLORIDE injection, solution
Generic name (nonproprietary): bupivacaine hydrochloride injection, solution
Active ingredients: Bupivacaine hydrochloride — 5 mg/mL
Dosage form: Injection, Solution
Route: Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207183
Marketing start: May 13, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1638_0f952dd8-92a8-2eb0-e063-6394a90a8c35SPL ID 0f952dd8-92a8-2eb0-e063-6394a90a8c35SPL set ID 06c15208-c600-7173-e063-6394a90a2f94RxCUI 1012404UNII 7TQO7W3VT8
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662163803 followed by a unit qualifier and the quantity

Package 51662-1638-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of bupivacaine hydrochloride injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see DOSAGE AND ADMINISTRATION ]. Limitations of Use Not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use [see DOSAGE AND ADMINISTRATION , CONTRAINDICATIONS , WARNINGS AND PRECAUTIONS ].…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1638

What is NDC 51662-1638?: 51662-1638 is the product NDC for BUPIVACAINE HYDROCHLORIDE injection, solution, Bupivacaine hydrochloride 5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: BUPIVACAINE HYDROCHLORIDE injection, solution.
What is the active ingredient?: Bupivacaine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for BUPIVACAINE HYDROCHLORIDE injection, solution?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 207183

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207183
Product	Strength	Form · route	Labeler	Product NDC
Bupivacaine Hci	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1581
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	A-S Medication Solutions	50090-4516
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	Eugia US LLC	55150-249
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	Eugia US LLC	55150-250
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	Medical Purchasing Solutions, LLC	71872-7133
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	Medical Purchasing Solutions, LLC	71872-7270
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	Sportpharm LLC	85766-305

BUPIVACAINE HYDROCHLORIDE injection, solution NDC 51662-1638